
Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) are trading sharply higher Tuesday morning following the release of the company’s second-quarter financial results and operational update.
What To Know: The biotechnology company posted a second-quarter net loss of $3.86 per share, which beat the analyst consensus estimate of a $10.73 loss per share. However, sales for the quarter were approximately $2.0 million, missing the estimated $2.6 million.